TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Sanofi-Aventis Norge AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
71,185
|
66,833
|
65,548 |
| Financial expenses |
399
|
116
|
124 |
| Earnings before taxes |
4,114
|
3,736
|
5,657 |
| Total assets |
30,306
|
31,303
|
37,887 |
| Current assets |
30,031
|
31,076
|
37,645 |
| Current liabilities |
29,049
|
30,834
|
33,047 |
| Equity capital |
1,256
|
469
|
4,840 |
| - share capital |
154
|
162
|
173 |
| Employees (average) | 64 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
4.1%
|
1.5%
|
12.8% |
| Turnover per employee | 1,112 | ||
| Profit as a percentage of turnover |
5.8%
|
5.6%
|
8.6% |
| Return on assets (ROA) |
14.9%
|
12.3%
|
15.3% |
| Current ratio |
103.4%
|
100.8%
|
113.9% |
| Return on equity (ROE) |
327.5%
|
796.6%
|
116.9% |
| Change turnover |
7,768
|
5,449
|
-4,240 |
| Change turnover % |
12%
|
9%
|
-6% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.